SCHEMBL30281177

SCHEMBL30281177

NC(=O)c1conc1OCC(F)F

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.33
MKNK2 Q9HBH9 1/20 0.32
MAP3K7 O43318 1/20 0.30
TAB1 Q15750 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23989860 0.86 MKNK2 (0.31) MKNK2
SCHEMBL30281343 0.79 PARP10 (0.40) MKNK2
SCHEMBL30281297 0.75 MKNK2 (0.32) CNR2MKNK2
SCHEMBL30281336 0.73 NNMT (0.40) MKNK2
SCHEMBL30281245 0.72 IRAK4 (0.45) MKNK2MAP3K7TAB1
SCHEMBL30616808 0.72 POLB (0.32)
SCHEMBL23990406 0.71 CA12 (0.36) CNR2MKNK2
SCHEMBL2528993 0.70 RAB9A (0.37) CNR2MKNK2
SCHEMBL30616810 0.69
SCHEMBL24768401 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143195-A1 IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17 Janssen Pharmaceutica NV (BE) 2023-03-08 EP disclosed